[Restenosis after percutaneous transluminal angioplasty: II. Possibilities for pharmacologic intervention].

Abstract

Reocclusion after percutaneous transluminal angioplasty is a major mechanism contributing to morbidity of patients after catheterization. Until now, pharmacological approaches to the prevention of restenosis were mostly disappointing, as only the early phase of thrombotic reocclusion, in which platelet activation is a major patho-physiological mechanism… (More)

Topics

Cite this paper

@article{Bger1996RestenosisAP, title={[Restenosis after percutaneous transluminal angioplasty: II. Possibilities for pharmacologic intervention].}, author={Rainer H. B{\"o}ger and Stefanie Margarethe Bode-B{\"o}ger and Heiko Alfke}, journal={VASA. Zeitschrift fur Gefasskrankheiten}, year={1996}, volume={25 1}, pages={21-31} }